Brazil's CADE Reviews EMS's $600 Million Acquisition of Sanofi's Generic Drug Business
Brazil's Administrative Council for Economic Defense (Cade) has initiated a review process for the a...
Sanofi Launches AI Field Concierge Based on Snowflake Cortex AI
Snowflake announced on the 9th that global pharmaceutical company Sanofi has launched a new AI agent...
UK's GSK in Talks to Acquire US Cancer Drug Maker Nuvalent for Over $9 Billion
On June 9, British pharmaceutical company GlaxoSmithKline (GSK) is in talks to acquire Nuvalent, a U...
Brazil's Ávita Care seeks approval for semaglutide weight-loss pen within June
Ávita Care is accelerating the submission of final supplementary materials to Brazil's National Heal...
Perioperative Apalutamide Reduces Risk of Distant Metastasis or Death by 20% in High-Risk Prostate Cancer
A new Phase 3 study in patients with high-risk localized or locally advanced prostate cancer (PCa) h...
France's Abivax UC Drug Phase III Positive with Safety Signal, Stock Plunges on June 2
French biotech company Abivax (Euronext Paris and Nasdaq: ABVX) saw its stock price experience sharp...
Ractigen Therapeutics' saRNA Reduces Fat by 45%, Accepted for ADA 2026 Poster Presentation
Ractigen Therapeutics announced that the latest research abstract on its first-in-class small activa...
Everest Medicines Acquires Rights to Develop, Manufacture, and Commercialize Presbyopia Treatment Eye Drops LNZ100 in Greater China
Everest Medicines (HKEX 1952.HK) announced that it has entered into an asset purchase agreement with...
EBGMP Evaluation Model Construction Fills Gap in Inspector Perspective
An evidence-based evaluation model for GMP inspectors (EBGMP, Evidence-based GMP) has been developed...
MannKind Showcases New Afrezza Pediatric Data at ADA
MannKind Corporation will present new clinical and real-world data on its products Afrezza (human in...